Exploring global complexities: Sino-US trade war impact, shifting economic frontlines & unexpected outcomes #GlobalLandscape https://fefd.link/5fDPf

Chinese biotechs & assets, a Q&A with Kanya Rajangam, MD, PhD Recently, I had a conversation with Dr. Kanya Rajangam, to discuss current perceptions about Chinese biotech, opportunities, language challenges, and risks.

To explore the changing #globallandscape of #drugdevelopment, Vibe Bio co-founder and CEO Alok Tayi recently had a conversation with Dr. Kanya Rajangam about the potential for #Chinesebiotech assets and programs in the US market.

Learn more in this post: vibebio.com/blog/chinese...